TCL Archive A “Screw-Up” Worked in MD Anderson’s Favor In Seven-Year Stint as U.S. News & World Report Top-Ranked Cancer Center July 19, 2013
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
